Publicaciones (66) Publicaciones de ANTONIO CRUZ RODRÍGUEZ Ver datos de investigación referenciados.

2023

  1. Beyond the Interface: Improved Pulmonary Surfactant-Assisted Drug Delivery through Surface-Associated Structures

    Pharmaceutics, Vol. 15, Núm. 1

2022

  1. Compositional, structural and functional properties of discrete coexisting complexes within bronchoalveolar pulmonary surfactant

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1864, Núm. 1

  2. Pulmonary surfactant and drug delivery: Vehiculization of a tryptophan-tagged antimicrobial peptide over the air-liquid interfacial highway

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 180, pp. 33-47

  3. The highly packed and dehydrated structure of preformed unexposed human pulmonary surfactant isolated from amniotic fluid

    American journal of physiology. Lung cellular and molecular physiology, Vol. 322, Núm. 2, pp. L191-L203

2021

  1. Author Correction: Molecular and biophysical mechanisms behind the enhancement of lung surfactant function during controlled therapeutic hypothermia (Scientific Reports, (2021), 11, 1, (728), 10.1038/s41598-020-79025-3)

    Scientific Reports

  2. Molecular and biophysical basis for the disruption of lung surfactant function by chemicals

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1863, Núm. 1

  3. Molecular and biophysical mechanisms behind the enhancement of lung surfactant function during controlled therapeutic hypothermia

    Scientific Reports, Vol. 11, Núm. 1

  4. Pulmonary surfactant and drug delivery: Vehiculization, release and targeting of surfactant/tacrolimus formulations

    Journal of Controlled Release, Vol. 329, pp. 205-222

  5. Structural hallmarks of lung surfactant: Lipid-protein interactions, membrane structure and future challenges

    Archives of Biochemistry and Biophysics, Vol. 703

  6. Towards the Molecular Mechanism of Pulmonary Surfactant Protein SP-B: At the Crossroad of Membrane Permeability and Interfacial Lipid Transfer

    Journal of Molecular Biology, Vol. 433, Núm. 3

2020

  1. Biophysical and biological impact on the structure and IgE-binding of the interaction of the olive pollen allergen Ole e 7 with lipids

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1862, Núm. 6

  2. In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition

    Scientific Reports, Vol. 10, Núm. 1

  3. Pulmonary Surfactant and Drug Delivery: An Interface-Assisted Carrier to Deliver Surfactant Protein SP-D Into the Airways

    Frontiers in Bioengineering and Biotechnology, Vol. 8

2019

  1. Interfacial Activity of Phasin PhaF from Pseudomonas putida KT2440 at Hydrophobic-Hydrophilic Biointerfaces

    Langmuir, Vol. 35, Núm. 3, pp. 678-686

  2. The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 144, pp. 230-243

2018

  1. Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin

    PLoS ONE, Vol. 13, Núm. 9

2017

  1. Effects of HIV-1 gp41-Derived Virucidal Peptides on Virus-like Lipid Membranes

    Biophysical Journal, Vol. 113, Núm. 6, pp. 1301-1310

  2. Efficient Interfacially Driven Vehiculization of Corticosteroids by Pulmonary Surfactant

    Langmuir, Vol. 33, Núm. 32, pp. 7929-7939

  3. Pulmonary surfactant and nanocarriers: Toxicity versus combined nanomedical applications

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1859, Núm. 9, pp. 1740-1748

2016

  1. Organization of the protein-lipid nanostructures Surfacen ® in correspondence with Its effectiveness as agent for stabilizing the air-liquid interface respiratory and first report as antileishmanial agent

    Biotecnologia Aplicada, Vol. 33, Núm. 4, pp. 4501-4506